1-7 of 7
Anella Yahiaoui
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

IGF1R as druggable target mediating PI3K-δ inhibitor resistance in a murine model of chronic lymphocytic leukemia

Annika Scheffold, Billy Michael Chelliah Jebaraj, Eugen Tausch, Johannes Bloehdorn, Paolo Ghia, Anella Yahiaoui, Anna Dolnik, Tamara Jacqueline Blätte, Lars Bullinger, Rashmi Priyadharshini Dheenadayalan, Li Li, Christof Schneider, Shih-Shih Chen, Nicholas Chiorazzi, Sascha Dietrich, Martina Seiffert, Stacey Tannheimer, Hartmut Döhner, Daniel Mertens, Stephan Stilgenbauer
Journal: Blood
Blood (2019) 134 (6): 534–547.
https://doi.org/10.1182/blood.2018881029
Published: 2019
Includes: Supplemental data
Journal Articles

Enhanced Efficacy of the SYK Inhibitor Entospletinib and Chemotherapy in Infant Acute Lymphoblastic Leukemia

Joseph Patrick Loftus, BS, Anella Yahiaoui, BS, Feng Shen, MDPhD, David Lopez, Igor Mikaelian, DVM, Patrick A Brown, MD, Stacey Tannheimer, PhD, Ann Forslund, PhD, Sarah K Tasian, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2611.
https://doi.org/10.1182/blood.V130.Suppl_1.2611.2611
Published: 2017
Journal Articles

Idelalisib Interferes with the Crosstalk of Follicular Lymphoma and Its Immune Microenvironment and Potentiates the Activity of ABT-199

Martina Guerrero-Hernandez, MSc, Alba Matas-Cespedes, PhD, Neus Serrat, PhD, Anella Yahiaoui, BS, Juan G Valero, PhD, Laura Magnano, MD, Alfredo Rivas-Delgado, MD, Dolors Colomer, PhD, Elias Campo, MD PhD, Armando Lopez-Guillermo, Gael Roue, PhD, Stacey Tannheimer, PhD, Patricia Pérez-Galán, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2813.
https://doi.org/10.1182/blood.V130.Suppl_1.2813.2813
Published: 2017
Journal Articles

Evaluation of Idelalisib with B-Cell Receptor or Orthogonal Pathway Inhibitors in Diffuse Large B-Cell Lymphoma Cell Lines in Vitro and In Vivo

Sarah Meadows, Anella Yahiaoui, Rick Sorensen, Zhi-Hua Cui, PhD, Robert Brockett, Kathleen S Keegan, PhD, Stacey Tannheimer
Journal: Blood
Blood (2016) 128 (22): 1845.
https://doi.org/10.1182/blood.V128.22.1845.1845
Published: 2016
Journal Articles

In Vivo modeling of Resistance to PI3Kδ Inhibitor Treatment Using EµTCL1-Tg Tumor Transfer Model

Annika Scheffold, Billy Michael Chelliah Jebaraj, Eugen Tausch, Anella Yahiaoui, Anna Dolnik, PhD, Tamara Jacqueline Blaette, M.sc., Lars Bullinger, MD, Christof Schneider, MD, Daniel Mertens, PhD, Veerendra Munugalavadla, Shih-Shih Chen, PhD, Nicholas Chiorazzi, MD, Stacey Tannheimer, Hartmut Döhner, MD, Stephan Stilgenbauer
Journal: Blood
Blood (2016) 128 (22): 190.
https://doi.org/10.1182/blood.V128.22.190.190
Published: 2016
Journal Articles

Investigation of the Mechanism of Idelalisib Resistance in the Follicular Lymphoma WSU-Fsccl Cell Line

Rick Sorensen, BS, Sarah Meadows, Anella Yahiaoui, BS, Li Li, PhD, Peng Yue, PhD, Adam Kashishian, BS, Christophe Queva, PhD, Stacey Tannheimer, PhD
Journal: Blood
Blood (2015) 126 (23): 2482.
https://doi.org/10.1182/blood.V126.23.2482.2482
Published: 2015
Journal Articles

Combination of Idelalisib and ONO/GS-4059 in Lymphoma Cell Lines Sensitive and Resistant to BTK Inhibitors

Stacey Tannheimer, PhD, Jia Liu, PhD, Rick Sorensen, BS, Anella Yahiaoui, BS, Sarah Meadows, Li Li, PhD, Peng Yue, PhD, Kathleen S Keegan, PhD, Jamie Bates, PhD, Daniel Tumas, PhD DVM, Christophe Queva, PhD
Journal: Blood
Blood (2015) 126 (23): 3697.
https://doi.org/10.1182/blood.V126.23.3697.3697
Published: 2015